Claro Advisors’s Bausch Health BHC Stock Holding History

Claro Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-105	Closed	-$3K	–	229
2018 Q4	$3K	Buy	+105	New	+$2.5K	﹤0.01%	848

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Claro Advisors's BHC Position: Q1 2019 in Review

Claro Advisors sold out of Bausch Health (BHC) in Q1 2019, closing a stake of 105 shares — an estimated $3K sold.

Claro Advisors first reported a position in BHC in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 349 funds tracked by Wall St. Rank hold BHC as of Q1 2019.

Claro Advisors reported no remaining Bausch Health position as of Q1 2019 after selling out during the quarter.
Claro Advisors sold 105 Bausch Health shares in Q1 2019, an estimated $3K.
Claro Advisors first reported a position in Bausch Health in Q4 2018 and held it in 1 quarter.
Claro Advisors's Bausch Health position peaked at $3K in Q4 2018.
349 funds tracked by Wall St. Rank held Bausch Health as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.